SONOMA PHARMACEUTICALS, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $40.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-06
- SONOMA PHARMACEUTICALS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $40.00K, a 91.07% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was -$38.00K, a 200.00% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $161.00K, a 373.53% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was -$56.00K, a 219.15% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2026 was $515.00K, a 195.98% increase from fiscal 2025.
- SONOMA PHARMACEUTICALS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $174.00K, a 8.07% increase from fiscal 2024.
- SONOMA PHARMACEUTICALS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $161.00K, a 6.94% decline from fiscal 2023.
- SONOMA PHARMACEUTICALS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $173.00K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $40.00K 10-Q · filed 2026-08-06 | $2.00K derived: sum of 2 quarters · filed 2026-08-06 | $163.00K derived: sum of 3 quarters · filed 2026-08-06 | $107.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | $123.00K derived: sum of 2 quarters · filed 2026-06-16 | $67.00K derived: sum of 3 quarters · filed 2026-06-16 | $515.00K 10-K · filed 2026-06-16 |
| 2025-12-31 | $161.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-10 | $105.00K derived: sum of 2 quarters · filed 2026-02-10 | $553.00K 10-Q · filed 2026-02-10 | $591.00K derived: sum of 4 quarters · filed 2026-06-16 |
| 2025-09-30 | -$56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-04 | $392.00K 10-Q · filed 2025-11-04 | $430.00K derived: sum of 3 quarters · filed 2026-06-16 | $464.00K derived: sum of 4 quarters · filed 2026-06-16 |
| 2025-06-30 | $448.00K 10-Q · filed 2025-08-07 | $486.00K derived: sum of 2 quarters · filed 2026-06-16 | $520.00K derived: sum of 3 quarters · filed 2026-06-16 | $567.00K derived: sum of 4 quarters · filed 2026-06-16 |
| 2025-03-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | $72.00K derived: sum of 2 quarters · filed 2026-06-16 | $119.00K derived: sum of 3 quarters · filed 2026-06-16 | $174.00K 10-K · filed 2026-06-16 |
| 2024-12-31 | $34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-05 | $81.00K derived: sum of 2 quarters · filed 2025-02-05 | $136.00K 10-Q · filed 2025-02-05 | $198.00K derived: sum of 4 quarters · filed 2025-06-17 |
| 2024-09-30 | $47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $102.00K 10-Q · filed 2024-11-07 | $164.00K derived: sum of 3 quarters · filed 2025-06-17 | $184.00K derived: sum of 4 quarters · filed 2025-06-17 |
| 2024-06-30 | $55.00K 10-Q · filed 2024-08-08 | $117.00K derived: sum of 2 quarters · filed 2025-06-17 | $137.00K derived: sum of 3 quarters · filed 2025-06-17 | $137.00K derived: sum of 4 quarters · filed 2025-06-17 |
| 2024-03-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-17 | $82.00K derived: sum of 2 quarters · filed 2025-06-17 | $82.00K derived: sum of 3 quarters · filed 2025-06-17 | $161.00K 10-K · filed 2025-06-17 |
| 2023-12-31 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | $20.00K derived: sum of 2 quarters · filed 2024-02-08 | $99.00K 10-Q · filed 2024-02-08 | $178.00K derived: sum of 4 quarters · filed 2024-06-17 |
| 2023-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | $79.00K 10-Q · filed 2023-11-13 | $158.00K derived: sum of 3 quarters · filed 2024-06-17 | $231.00K derived: sum of 4 quarters · filed 2024-06-17 |
| 2023-06-30 | $79.00K 10-Q · filed 2023-08-10 | $158.00K derived: sum of 2 quarters · filed 2024-06-17 | $231.00K derived: sum of 3 quarters · filed 2024-06-17 | $221.00K derived: sum of 4 quarters · filed 2024-06-17 |
| 2023-03-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-17 | $152.00K derived: sum of 2 quarters · filed 2024-06-17 | $142.00K derived: sum of 3 quarters · filed 2024-06-17 | $173.00K 10-K · filed 2024-06-17 |
| 2022-12-31 | $73.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-14 | $63.00K derived: sum of 2 quarters · filed 2023-02-14 | $94.00K 10-Q · filed 2023-02-14 | |
| 2022-09-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-14 | $21.00K 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | $31.00K 10-Q · filed 2022-08-11 | |||
| 2021-12-31 | $72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-11 | $81.00K derived: sum of 2 quarters · filed 2022-02-11 | $148.00K 10-Q · filed 2022-02-11 | |
| 2021-09-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-15 | $76.00K 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | $67.00K 10-Q · filed 2021-08-16 | |||
| 2021-03-31 | $215.00K 10-K · filed 2021-07-14 | |||
| 2020-03-31 | $681.00K 10-K · filed 2020-07-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |